Evidence map›Paper›PMID 33472651›Full record

ArticleWorld journal of surgical oncology2021

Atypical parathyroid adenoma: clinical and anatomical pathologic features.

Alessandro Galani, Riccardo Morandi, Mira Dimko, Sarah Molfino, Carla Baronchelli, Silvia Lai, Federico Gheza, Carlo Cappelli, Claudio Casella

Open access · goldAbstract read
In one paragraph

Article in World journal of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. The Diagnostic Accuracy of [Diagnostics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Avoiding overdiagnosis of parathyroid carcinoma.Virchows Archiv : an international journal of pathology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Alessandro GalaniDepartment of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy. a.galani@unibs.it.ORCID http://orcid.org/0000-0001-5683-6841
Riccardo MorandiDepartment of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy.
Mira DimkoNephrology and Dialysis Unit, ASST Carlo Poma, Mantova, Italy.
Sarah MolfinoDepartment of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy.
Carla BaronchelliInstitute of Pathology, Spedali Civili, Brescia, Italy.
Silvia LaiDepartment of Translation and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Federico GhezaDepartment of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy.
Carlo CappelliDepartment of Clinical and Experimental Sciences, Unit of Endocrinology and Metabolism, University of Brescia, Brescia, Italy.
Claudio CasellaDepartment of Molecular and Translational Medicine, Surgical Clinic, University of Brescia, Brescia, Italy.
University of Brescia · ITAzienda Ospedaliera Carlo Poma · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary hyperparathyroidism is an endocrine pathology that affects calcium metabolism. Patients with primary hyperparathyroidism have high concentrations of serum calcium or high concentrations of parathyroid hormone, or incorrect parathyroid hormone levels for serum calcium values. Primary hyperparathyroidism is due to the presence of an adenoma/single-gland disease in 80-85%. Multiple gland disease or hyperplasia accounts for 10-15% of cases of primary hyperparathyroidism. Atypical parathyroid adenoma and parathyroid carcinoma are both responsible for about 1.2-1.3% and 1% or less of primary hyperparathyroidism, respectively.

methodsWe performed a retrospective cohort study and enrolled 117 patients with primary hyperparathyroidism undergoing minimally invasive parathyroidectomy. Histological and immunohistochemical examination showed that 107 patients (91.5%) were diagnosed with typical adenoma (group A), while 10 patients (8.5%) were diagnosed with atypical parathyroid adenoma (group B). None of the patients were affected by parathyroid carcinoma.

resultsSignificant statistical differences were found in histological and immunohistochemical parameters as pseudocapsular invasion (p <  0.001), bands of fibrosis (p <  0.001), pronounced trabecular growth (p <  0.001), mitotic rates of > 1/10 high-power fields (HPFs) (p <  0.001), nuclear pleomorphism (p = 0.036), thick capsule (p <  0.001), Ki-67+ > 4% (p <  0.001), galectin-3 + (p = 0.002), and protein gene product (PGP) 9.5 + (p = 0.038).

conclusionsAtypical parathyroid adenoma is a tumor that has characteristics both of typical adenoma and parathyroid carcinoma. The diagnosis is reached by excluding with strict methods the presence of malignancy criteria. Atypical parathyroid adenoma compared to typical adenoma showed significant clinical, hematochemical, histological, and immunohistochemical differences. We did not find any disease relapse in the 10 patients with atypical parathyroid adenoma during 60 months of follow-up time.

Indexed as

AdenomaParathyroid NeoplasmsHumansParathyroidectomyParathyroid GlandsParathyroid HormonePrognosisRetrospective StudiesParathyroid HormoneAtypical parathyroid adenomaMinimally invasive parathyroidectomyParathyroid carcinomaPrimary hyperparathyroidismTypical adenoma

Identifiers

PMID33472651
PMCPMC7818751
OpenAlexW3122537037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.